QNAQ Trademark
Trademark Overview
On Tuesday, February 26, 2002, a trademark application was filed for QNAQ with the United States Patent and Trademark Office. The USPTO has given the QNAQ trademark a serial number of 78111109. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, November 7, 2003. This trademark is owned by Pfizer Inc.. The QNAQ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations; pharmaceutical preparations for the prevention and treatment of stroke and ischemia
General Information
| Serial Number | 78111109 |
| Word Mark | QNAQ |
| Filing Date | Tuesday, February 26, 2002 |
| Status | 601 - ABANDONED - EXPRESS |
| Status Date | Friday, November 7, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, October 8, 2002 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations; pharmaceutical preparations for the prevention and treatment of stroke and ischemia |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 5, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 100175755 |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 100175755 |
Trademark Events
| Event Date | Event Description |
| Friday, November 7, 2003 | ABANDONMENT - EXPRESS MAILED |
| Monday, November 10, 2003 | PAPER RECEIVED |
| Monday, May 12, 2003 | EXTENSION 1 GRANTED |
| Tuesday, March 25, 2003 | EXTENSION 1 FILED |
| Tuesday, March 25, 2003 | TEAS EXTENSION RECEIVED |
| Tuesday, December 31, 2002 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, October 8, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 18, 2002 | NOTICE OF PUBLICATION |
| Friday, July 26, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, July 19, 2002 | ASSIGNED TO EXAMINER |
